Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 4Enrolling by invitation 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colitis, Ulcerative 4Inflammatory Bowel Diseases 3Crohn Disease 3Arthritis, Rheumatoid 3Graft vs Host Disease 2Cachexia 2Anorexia 2Recurrence 1Rare Diseases 1Psoriasis 1Pancreatic Neoplasms 1Lymphoma 1Lung Neoplasms 1Kidney Transplantation 1Inflammation 1Hypertension 1Gastrointestinal Diseases 1Fatigue 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Bipolar Disorder 1Arthritis, Psoriatic 1Anemia 1

Interventions

etrolizumab 5Infliximab 4Adalimumab 3golimumab 2CT-P13 2peficitinib 1Sutures 1Surgical Instruments 1Ringer's Lactate 1Proctectomy 1Pneumococcal Vaccines 1Papillomavirus Vaccines 1Methylprednisolone 1Mesalamine 1Lysine Acetyltransferase 5 1Laparoscopy 1Injections 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Eicosapentaenoic Acid 1CVD protocol 1ABX464 12-(3',4'-dihydroxyphenyl-1-azo)benzimidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Colitis, Ulcerative × Infliximab × Clear all
NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed
174 enrolled

Colitis, Ulcerative, Recurrence

NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed
397 enrolled 32 charts

Colitis, Ulcerative

NCT03452501 2021-02-23

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

Hikma Pharmaceuticals LLC

Completed
157 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡